Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;35(6):1849-1860.
doi: 10.1007/s11606-020-05731-3. Epub 2020 Mar 10.

Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials

Jill J Hall  1 , Dean T Eurich  2 , Danielle Nagy  3 , Lisa Tjosvold  4 , John-Michael Gamble  5
Affiliations
Review

Thiazide Diuretic-Induced Change in Fasting Plasma Glucose: a Meta-analysis of Randomized Clinical Trials

Jill J Hall et al. J Gen Intern Med. 2020 Jun.

Abstract

Background: Prior meta-analyses measuring thiazide-induced glycemic change have demonstrated an increased risk of incident diabetes; however, this measure's definition has changed over time.

Aim: To determine the magnitude of change in fasting plasma glucose (FPG) for thiazide diuretics.

Data sources: A research librarian designed and conducted searches in Medline®, EMBASE, and EBM Reviews-Cochrane Central Register of Controlled Trials (inception through July 2018) and International Pharmaceutical Abstracts (inception to December 2014).

Study selection: Randomized, controlled trials comparing a thiazide or thiazide-like diuretic to any comparator reporting FPG were identified. Trials enrolling < 50 participants, those with a follow-up period of < 4 weeks, and conference abstracts were excluded.

Data extraction: Independent duplicate screening of citations and full-text articles, data extraction, and assessment of risk of bias was conducted.

Data synthesis: Ninety-five studies were included (N = 76,608 participants), with thiazides compared with placebo, beta-blockers, calcium channel blockers, renin-angiotensin-aldosterone-system inhibitors, potassium-sparing diuretic, and others alone or in combination. Thiazide diuretics marginally increased FPG (weighted mean difference 0.20 mmol/L (95% CI 0.15-0.25); I2 = 84%) (1 mmol/L = 18 mg/dL). Results did not change substantially when considering dose or duration, comparing thiazides with placebo or an active comparator, or using thiazides as monotherapy or combination therapy, even when combined with a potassium-correcting agent.

Conclusion: Thiazide diuretics have a small and clinically unimportant impact on FPG.

Keywords: fasting plasma glucose; meta-analysis; randomized controlled trial; thiazide diuretic.

PubMed Disclaimer

Conflict of interest statement

No author has any financial arrangements or potential conflicts of interest to disclose with regard to products in this manuscript.

Figures

Figure 1
Figure 1
Summary of study retrieval and identification for meta-analysis.
Figure 2
Figure 2
Summary of risk of bias for trials included in meta-analysis.
Figure 3
Figure 3
Summary of forest plot demonstrating the weighted mean difference in fasting blood glucose (1 mmol/L = 18 mg/dL) in patients treated with thiazide diuretics overall and in sensitivity and subgroup analyses.
See this image and copyright information in PMC

References

    1. Nerenberg KA, Zarnke KB, Leung AA, et al. Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018;34(5):506–525. - PubMed
    1. James PA, Oparil S, Carter BL, et al. Evidence-Based Guideline for the Management of High Blood Pressure in Adults. JAMA. 2014;311(5):507–520. - PubMed
    1. Carter BL, Einhorn PT, Brands M, et al. Thiazide-induced dysglycemia: Call for research from a working group from the national heart, lung, and blood institute. Hypertension. 2008;52(1):30–36. - PubMed
    1. Elliott WJ. Effects of potassium-sparing versus thiazide diuretics on glucose tolerance: New data on an old topic. Hypertension. 2012;59(5):911–912. - PubMed
    1. Eriksson JW, Jansson PA, Carlberg B, et al. Hydrochlorothiazide, but not candesartan, aggravates insulin resistance and causes visceral and hepatic fat accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) study. Hypertension. 2008;52(6):1030–1037. - PubMed